# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5136199 | Physicochemical | Kinetic aqueous solubility of the compound in in 4% DMSO/HEPES buffer at pH 8 incubated for 20 hrs by NMR analysis | 15 | ALA5131540 | small-molecule physicochemical format | Scientific Literature | ||
2. | ALA5136201 | Binding | Inhibition of human C-terminal nanoLuc-tagged BCL6 expressed in HEK293T cells co-expressing HaloTagged-SMRT using NanoBRET furimazine as substrate incubated for 6 hrs by NanoBRET assay | Homo sapiens | 12 | ALA5131540 | cell-based format | Scientific Literature | |
3. | ALA5136202 | Binding | Inhibition of human N-terminal thioredoxin 6-His tagged BCL6 BTB domain (5 to 129 residues) expressed in Escherichia coli BL21-AI using BCOR-AF633 peptide as substrate incubated for 2 hrs by TR-FRET assay | Homo sapiens | 24 | ALA5131540 | assay format | Scientific Literature | |
4. | ALA5136203 | Functional | Antiproliferative activity against human OCI-Ly1 cells assessed as cell growth inhibition mesured after 14 days by CellTiter-Glo luminescent assay | Homo sapiens | 2 | ALA5131540 | cell-based format | Scientific Literature | |
5. | ALA5136204 | Functional | Antiproliferative activity against human KARPAS-422 cells assessed as cell growth inhibition mesured after 14 days by CellTiter-Glo luminescent assay | Homo sapiens | 2 | ALA5131540 | cell-based format | Scientific Literature | |
6. | ALA5136205 | Functional | Antiproliferative activity against human OCILY3 cells assessed as cell growth inhibition mesured after 14 days by CellTiter-Glo luminescent assay | Homo sapiens | 2 | ALA5131540 | cell-based format | Scientific Literature | |
7. | ALA5136206 | ADME | Permeability of the compound at pH 7.4 by PAMPA | 3 | ALA5131540 | assay format | Scientific Literature |